Description

Glow is a precisely formulated advanced research blend developed exclusively by Apex Sequence Labs, combining three of the most extensively studied and scientifically compelling peptides in regenerative biology, skin science, and tissue repair research into a single, synergistically designed compound stack. Comprising BPC 157 (Body Protection Compound-157) at 10mg, GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) at 50mg, and TB-500 (Thymosin Beta-4) at 10mg, Glow represents a curated multi-peptide research tool engineered to explore the convergent and potentially synergistic effects of simultaneous multi-pathway activation across tissue regeneration, angiogenesis, collagen synthesis, anti-inflammatory signalling, and cellular repair biology. Each component of the Glow blend has been individually validated to the highest purity standards, and the blend has been precision-formulated to deliver consistent, reliable, and reproducible results for researchers investigating the intersecting biology of skin repair, wound healing, and regenerative medicine. Apex Sequence Labs offers Glow at the highest standards of quality, manufactured under strict quality control protocols to ensure consistency and reliability for advanced scientific investigation.

Blend Composition
ComponentQuantityClassBPC 157 (Body Protection Compound-157)10mgPentadecapeptideGHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper)50mgCopper TripeptideTB-500 (Thymosin Beta-4)10mgActin-Sequestering Peptide

The Science Behind the Blend
BPC 157 (10mg)
Body Protection Compound-157 is a synthetic 15 amino acid pentadecapeptide derived from a protective protein found in human gastric juice. In the context of the Glow blend, BPC 157 contributes its extensively researched pro-angiogenic, anti-inflammatory, and tissue repair properties. Research has documented BPC 157’s capacity to stimulate angiogenesis through upregulation of VEGF expression and nitric oxide pathways, accelerate wound closure through fibroblast migration and proliferation, modulate inflammatory cytokine cascades, and promote the healing of connective tissue structures including tendons, ligaments, and dermal layers. Its well-characterised gastrointestinal cytoprotective properties also contribute a systemic tissue-protective dimension to the blend’s overall research profile.
GHK-Cu (50mg)
Glycyl-L-Histidyl-L-Lysine Copper is a naturally occurring copper complex tripeptide found in human plasma that represents one of the most extensively studied peptides in dermatological and skin biology research. Contributing the highest quantity within the Glow blend, GHK-Cu anchors the formulation’s skin biology research profile through its documented capacity to stimulate collagen and glycosaminoglycan synthesis, activate skin remodelling processes, upregulate antioxidant enzyme expression, modulate inflammatory signalling, stimulate hair follicle biology, and — most remarkably — influence gene expression patterns across thousands of human genes toward profiles associated with healthier cellular function. GHK-Cu’s copper-dependent biological activity and its capacity to reset gene expression in aged or damaged cells make it the central skin science component of the Glow research blend.
TB-500 (Thymosin Beta-4) (10mg)
Thymosin Beta-4 is a naturally occurring 43 amino acid actin-sequestering peptide with potent regenerative, anti-inflammatory, and angiogenic properties. In the context of the Glow blend, TB-500 contributes its well-researched capacity to promote cell migration and tissue repair through actin polymerisation modulation, stimulate new blood vessel formation, reduce inflammation through NF-?B pathway modulation, promote keratinocyte migration critical to wound re-epithelialisation, and support the regeneration of multiple tissue types including skin, cardiac, neural, and connective tissue. TB-500’s ability to promote keratinocyte and endothelial cell migration positions it as a particularly relevant complement to GHK-Cu’s collagen-stimulating and gene expression-modulating properties within the Glow research framework.

Research Areas of Interest
The Glow blend has been formulated to investigate the convergent and potentially synergistic effects of its three component peptides across the following key research domains:

Skin Biology & Dermatological Research – The primary research focus of the Glow blend, combining GHK-Cu’s collagen synthesis stimulation and gene expression modulation, BPC 157’s pro-angiogenic and anti-inflammatory effects, and TB-500’s keratinocyte migration promotion into a comprehensive multi-mechanism skin biology research tool. Studies utilising the Glow blend can investigate whether simultaneous activation of multiple skin repair pathways produces additive or synergistic effects on dermal remodelling, skin barrier integrity, and the molecular markers of skin ageing and repair.
Wound Healing & Tissue Repair Research – Each component of the Glow blend independently demonstrates pro-wound healing properties through distinct and complementary mechanisms. BPC 157 accelerates wound closure through fibroblast activation and VEGF-mediated angiogenesis, GHK-Cu stimulates collagen deposition and matrix remodelling, and TB-500 promotes keratinocyte migration and re-epithelialisation. Together, the Glow blend offers researchers a uniquely comprehensive multi-pathway wound healing research tool that addresses the vascular, structural, cellular, and inflammatory dimensions of wound repair simultaneously.
Angiogenesis & Vascular Research – Both BPC 157 and TB-500 independently demonstrate pro-angiogenic properties through distinct receptor-mediated and signalling pathway mechanisms, while GHK-Cu contributes additional VEGF-modulating activity. The convergent angiogenic potential of the Glow blend provides researchers with a powerful multi-mechanism tool for studying new blood vessel formation, microvascular network development, and the vascular component of tissue repair and regeneration.
Collagen Synthesis & Extracellular Matrix Research – GHK-Cu’s well-documented capacity to stimulate collagen types I and III synthesis, combined with BPC 157’s fibroblast-activating and TB-500’s tissue remodelling properties, positions the Glow blend as a comprehensive research tool for investigating multi-peptide effects on extracellular matrix composition, collagen crosslinking, glycosaminoglycan production, and overall connective tissue biology.
Anti-Inflammatory & Immunomodulatory Research – All three components of the Glow blend demonstrate anti-inflammatory properties through partially overlapping and partially distinct mechanisms. BPC 157 modulates pro-inflammatory cytokine cascades, GHK-Cu downregulates inflammatory gene expression and TNF-? production, and TB-500 suppresses NF-?B-mediated inflammatory signalling. The combined anti-inflammatory profile of the Glow blend provides researchers with a multi-target anti-inflammatory research tool for studying peptide-mediated resolution of tissue inflammation in skin and connective tissue research models.
Gene Expression & Epigenetic Research – GHK-Cu’s remarkable documented capacity to influence the expression of over 4,000 human genes — resetting aged or damaged cellular gene expression profiles toward healthier patterns — represents a uniquely powerful research dimension within the Glow blend. Studies can investigate whether the presence of BPC 157 and TB-500 modifies, enhances, or interacts with GHK-Cu’s gene expression modulating activity in skin and connective tissue cell types.
Hair Follicle Biology Research – GHK-Cu’s well-researched capacity to stimulate hair follicle size, prolong the anagen growth phase, and promote follicular activity, combined with TB-500’s cell migration-promoting properties and BPC 157’s angiogenic effects on follicular vasculature, positions the Glow blend as a scientifically compelling multi-peptide research tool for studying the vascular, structural, and molecular biology of hair follicle function and regeneration.
Ageing Biology & Anti-Ageing Research – The convergent anti-ageing research properties of the three Glow components — GHK-Cu’s gene expression resetting and antioxidant upregulation, BPC 157’s cytoprotective and tissue-protective effects, and TB-500’s regenerative and anti-inflammatory properties — combine to create a multi-mechanism research blend for investigating peptide-mediated modulation of the molecular hallmarks of skin and tissue ageing.
Regenerative Medicine Research – As a multi-peptide blend targeting angiogenesis, collagen synthesis, cell migration, anti-inflammatory signalling, and gene expression modulation simultaneously, the Glow blend provides researchers with a comprehensive investigational tool for studying multi-pathway regenerative medicine strategies in skin, connective tissue, and wound healing research models.

Synergy Rationale
The scientific rationale for the Glow blend’s specific component combination is grounded in the complementary and partially non-overlapping mechanisms of its constituent peptides:

Vascular Layer — BPC 157 and TB-500 both promote angiogenesis through distinct mechanisms (VEGF/NO pathway vs. actin-mediated endothelial cell migration), providing dual-pathway vascular support to tissue repair and skin biology research models
Structural Layer — GHK-Cu drives collagen and glycosaminoglycan synthesis while BPC 157 activates fibroblasts and TB-500 promotes tissue remodelling, addressing the structural extracellular matrix dimension of skin repair through three complementary mechanisms simultaneously
Cellular Migration Layer — TB-500’s actin-sequestering activity and keratinocyte migration promotion complements BPC 157’s fibroblast chemotaxis effects, providing dual-mechanism cellular recruitment support to wound re-epithelialisation research models
Gene Expression Layer — GHK-Cu’s broad gene expression modulating activity operates at the transcriptional level across thousands of genes, providing a systemic cellular reprogramming dimension to the Glow blend that operates in parallel with and potentially amplifies the receptor-mediated effects of BPC 157 and TB-500
Anti-Inflammatory Layer — The convergent but mechanistically distinct anti-inflammatory effects of all three components provide multi-target inflammatory pathway suppression, potentially addressing a broader spectrum of inflammatory mediators than any single component could achieve alone

Individual Component Specifications
BPC 157

Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular Formula: C??H??N??O??
Molecular Weight: 1419.5 g/mol
Purity: ?99% (HPLC verified)

GHK-Cu

Sequence: Gly-His-Lys · Cu²?
Molecular Formula: C??H??CuN?O?
Molecular Weight: 403.9 g/mol
Purity: 99% (HPLC verified)

TB-500 (Thymosin Beta-4)

Molecular Formula: C???H???N??O??S
Molecular Weight: ~4963.5 g/mol
Purity: 99% (HPLC verified)

Quality Assurance
All Apex Sequence Labs peptides and blends are:

Each component independently synthesised using advanced solid-phase peptide synthesis (SPPS)
Individually third-party tested via HPLC and Mass Spectrometry prior to blending
Precision-blended under controlled, sterile, ISO-compliant laboratory conditions
Final blend tested for composition accuracy, purity, and sterility
Supplied with a Certificate of Analysis (CoA) for each component available upon request

Packaging & Storage

Available in: Single vial containing BPC 157 10mg + GHK-Cu 50mg + TB-500 10mg
Storage: Store lyophilized blend at 20°C away from light and moisture
Once reconstituted: Store at 4°C and use within 28 days
Recommended diluent: Bacteriostatic water or sterile water for injection
Shelf life: 24 months when stored correctly in lyophilized form

Why Choose Apex Sequence Labs Glow?

– Three independently 99% purity verified components
– Precision-formulated blend ratios based on published research literature
– Each component individually HPLC and Mass Spectrometry tested
– Final blend sterility and composition verified
– Certificate of Analysis available for each component
– Produced in ISO-compliant cleanroom facilities
– Fast, discreet shipping
– Dedicated researcher support team

– Research Use Only Disclaimer
Glow (BPC 157 + GHK-Cu + TB-500) supplied by Apex Sequence Labs is intended strictly for in vitro and in vivo laboratory research purposes only. This product is NOT intended for human or veterinary use, is NOT a drug or dietary supplement, and has NOT been evaluated or approved by the FDA or any other regulatory authority for therapeutic, diagnostic, or prophylactic use. By purchasing this product, the buyer confirms they are a qualified researcher and accepts full responsibility for its lawful and ethical use in accordance with all applicable local, state, and federal regulations.